Literature DB >> 12852486

Why is glaucoma associated with exfoliation syndrome?

Robert Ritch1, Ursula Schlötzer-Schrehardt, Anastasios G P Konstas.   

Abstract

Exfoliation syndrome (XFS) is an age-related, generalized disorder of the extracellular matrix characterized by production and progressive accumulation of a fibrillar material in tissues throughout the anterior segment and also in connective tissue portions of various visceral organs. Mature exfoliation fibrils are composed of 8-10 nm microfibrils resembling elastic microfibrils. The exact chemical composition of exfoliation material (XFM) remains unknown. It appears to consist of a complex glycoprotein/ proteoglycan structure composed of a protein core surrounded by abundant glycoconjugates. The protein components include both non-collagenous basement membrane components and epitopes of the elastic fiber system, particularly components of elastic microfibrils. Overall, XFS is the most common identifiable cause of glaucoma, accounting for the majority of cases in some countries, and causing both open-angle glaucoma and angle-closure glaucoma. Iridolenticular friction leads to loss of XFM from the anterior lens surface and disruption of the iris pigment epithelium, resulting in pigment deposition in the trabecular meshwork, which also produces XFM locally. The primary cause of chronic pressure elevation appears to be the active involvement of trabecular cells and Schlemm's canal cells in particular, in the generalized pathologic matrix process with subsequent degenerative changes of Schlemm's canal and adjacent tissues. Narrow angles and angle-closure are common in XFS. Pupillary block may be caused by a combination of posterior synechiae, increased iris thickness or rigidity, or anterior lens movement secondary to zonular weakness or dialysis. Enlargement of the lens due to cataract formation and relative pupillary constriction are additional factors.

Entities:  

Mesh:

Year:  2003        PMID: 12852486     DOI: 10.1016/s1350-9462(02)00014-9

Source DB:  PubMed          Journal:  Prog Retin Eye Res        ISSN: 1350-9462            Impact factor:   21.198


  73 in total

1.  The elastin fiber system between and adjacent to collector channels in the human juxtacanalicular tissue.

Authors:  Cheryl R Hann; Michael P Fautsch
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-01-05       Impact factor: 4.799

2.  Nailfold capillary morphology in exfoliation syndrome.

Authors:  C C Cousins; J H Kang; C Bovee; J Wang; S H Greenstein; A Turalba; L Q Shen; S Brauner; T Boumenna; S Blum; H Levkovitch-Verbin; R Ritch; J L Wiggs; P A Knepper; L R Pasquale
Journal:  Eye (Lond)       Date:  2017-01-13       Impact factor: 3.775

Review 3.  Association of clusterin (CLU) variants and exfoliation syndrome: An analysis in two Caucasian studies and a meta-analysis.

Authors:  Bao J Fan; Louis R Pasquale; Jae H Kang; Hani Levkovitch-Verbin; Jonathan L Haines; Janey L Wiggs
Journal:  Exp Eye Res       Date:  2015-08-10       Impact factor: 3.467

4.  Individual molecular response to elevated intraocular pressure in perfused postmortem human eyes.

Authors:  Núria Comes; Teresa Borrás
Journal:  Physiol Genomics       Date:  2009-04-28       Impact factor: 3.107

5.  A Comparison of Resource Use and Costs of Caring for Patients With Exfoliation Syndrome Glaucoma Versus Primary Open-Angle Glaucoma.

Authors:  Siddarth Rathi; Chris Andrews; David S Greenfield; Joshua D Stein
Journal:  Am J Ophthalmol       Date:  2019-01-08       Impact factor: 5.258

Review 6.  Growth Factors, Oxidative Damage, and Inflammation in Exfoliation Syndrome.

Authors:  Teresa Borrás
Journal:  J Glaucoma       Date:  2018-07       Impact factor: 2.503

7.  High-sensitivity C-reactive Protein and Tumor Necrosis Factor Alpha in Pseudoexfoliation Syndrome.

Authors:  Rana Sorkhabi; Amir Ghorbanihaghjo; Mohamadhossein Ahoor; Mehriar Nahaei; Nadereh Rashtchizadeh
Journal:  Oman Med J       Date:  2013-01

8.  Clusterin and complement activation in exfoliation glaucoma.

Authors:  Ivo Doudevski; Agueda Rostagno; Mary Cowman; Jeffrey Liebmann; Robert Ritch; Jorge Ghiso
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-04-17       Impact factor: 4.799

9.  Directed therapy for exfoliation syndrome.

Authors:  Allison Angelilli; Robert Ritch
Journal:  Open Ophthalmol J       Date:  2009-09-17

10.  Evaluation of LOXL1 polymorphisms in exfoliation syndrome in a Chinese population.

Authors:  Ling Chen; Liyun Jia; Ningli Wang; Guangxian Tang; Chun Zhang; Sujie Fan; Wenru Liu; Hailin Meng; Wotan Zeng; Ningpu Liu; Huaizhou Wang; Hongyan Jia
Journal:  Mol Vis       Date:  2009-11-14       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.